Review finds uneven care for Wernicke encephalopathy linked to alcohol use
The evidence review reports missed diagnoses, delayed care, and wide variation in thiamine use, while the best regimen remains uncertain.
Moderate evidenceReviewInterpret with caution
Medical disclaimer: This article summarizes research findings and is for informational purposes only. It is not medical advice.
Editorial illustration — not from the study.
Researchers mapped evidence on how Wernicke encephalopathy is diagnosed, prevented, and treated in alcohol-related clinical settings. The included evidence came from randomized trials, observational studies, clinical audits, and implementation reports, rather than from one new patient study.
Across the reviewed studies, missed or delayed treatment and frequent use of oral thiamine in situations considered high risk were reported. More structured care was associated with earlier treatment and more frequent use of thiamine given by injection or intravenously, but these findings mainly describe patterns of care and do not prove that one approach is superior.
The question reviewed
The researchers conducted a scoping review following PRISMA-ScR guidance. They searched electronic databases and trial registries for studies about diagnosis, prevention, or treatment of Wernicke encephalopathy among people with alcohol use disorder or clinically significant alcohol use. Twenty-six studies were included, covering randomized controlled trials, observational research, clinical audits, and reports focused on putting recommendations into practice.
What the review concluded
The evidence was limited and heterogeneous. Only two randomized controlled trials assessed thiamine regimens, and they did not establish a consensus about the optimal dose or regimen. Diagnostic criteria varied substantially, including inconsistent use of formal criteria such as the Caine criteria.
Observational studies and prescribing audits consistently reported undertreatment, including delays in starting therapy and frequent use of oral thiamine in high-risk situations. Studies of more protocol-based or guideline-concordant care more often reported earlier treatment and use of parenteral thiamine in suspected or confirmed cases. Because much of this evidence was observational, these patterns show associations in care, not proof that a particular protocol causes better patient outcomes.
Where this may apply
The findings are most relevant to clinical care involving adults with alcohol use disorder or clinically significant alcohol use who may be at risk of Wernicke encephalopathy. They may not apply to people outside those populations, and the review does not provide evidence for an individual person's diagnosis or treatment. The findings describe broad patterns and uncertainties across studies rather than a confirmed regimen or outcome for every patient.
Why it matters
Wernicke encephalopathy is a serious neurological condition associated with alcohol-related illness, and the review indicates that it may be missed or managed inconsistently in clinical settings. The work highlights uncertainty in diagnosis and treatment practice, as well as gaps between recommendations and reported care. It does not determine which thiamine regimen is most effective or show that a specific management approach improves outcomes.
Limitations & evidence assessment
The review included only 26 studies, and the evidence was described as limited and heterogeneous. Only two randomized trials evaluated thiamine regimens, while much of the remaining evidence came from observational studies, audits, or implementation reports that can describe care patterns but cannot establish cause and effect. Diagnostic definitions varied between studies, and the abstract provides limited detail about the size, quality, and individual characteristics of the included populations. As a scoping review, the work maps available evidence rather than combining results into a single estimate of treatment effectiveness.
Why this evidence level: This was a scoping review of 26 studies, but the underlying evidence was limited and varied widely. Only two randomized trials examined thiamine regimens, and the review found no agreement about the best regimen, so the overall evidence does not support a high-confidence clinical conclusion.
Evidence levels are editorial estimates derived from study metadata — they are not clinical appraisals.
// Source
Addiction Science & Clinical Practice · 2026 · DOI: 10.1186/s13722-026-00687-x
Researchers combined genetic data from more than 1 million human participants to study factors associated with endometriosis. They identified 58 genomic regions, including 27 not previously reported, and used additional molecular analyses to implicate 314 genes. These findings point to possible biological pathways for further research, but they do not establish causes or demonstrate that any treatment will work.
Researchers systematically reviewed laboratory studies of how temperature affects the time it takes arboviruses to become transmissible inside mosquitoes. Across 53 studies covering 17 viruses, higher temperatures were generally linked with greater transmission efficiency and a shorter time to infectiousness for Zika and West Nile viruses, while results for several other viruses were unclear.
This systematic review and meta-analysis examined whether ultra-low-dose computed tomography (CT) can detect pulmonary, or lung, nodules while using less radiation than standard-dose CT. Across 42 studies involving 15,792 patients, pooled sensitivity for nodule detection was 91.9%, but results varied greatly between studies. The review also found that ultra-low-dose CT used an average effective dose of 0.22 millisieverts (mSv), while detection was less reliable for some small or hazy nodules and in patients with a high body mass index.